BHK Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,790
Closed -$399K 65
2022
Q4
$399K Sell
7,790
-1,548
-17% -$74.2K 0.22% 39
2022
Q3
$409K Sell
9,338
-1,290
-12% -$62.7K 0.21% 40
2022
Q2
$557K Buy
10,628
+619
+6% +$31.5K 0.25% 32
2022
Q1
$518K Buy
10,009
+4
+0% +$208 0.22% 33
2021
Q4
$591K Buy
10,005
+4
+0% +$198 0.23% 32
2021
Q3
$430K Sell
10,001
-106
-1% -$4.7K 0.18% 40
2021
Q2
$396K Hold
10,107
0.16% 44
2021
Q1
$372K Buy
10,107
+83
+0.8% +$2.95K 0.17% 43
2020
Q4
$369K Buy
10,024
+95
+1% +$3.48K 0.17% 42
2020
Q3
$346K Buy
9,929
+448
+5% +$15.7K 0.19% 39
2020
Q2
$294K Buy
9,481
+1,421
+18% +$48.3K 0.17% 44
2020
Q1
$250K Sell
8,060
-10,237
-56% -$349K 0.18% 43
2019
Q4
$680K Sell
18,297
-2,148
-11% -$76.5K 0.39% 29
2019
Q3
$697K Buy
20,445
+364
+2% +$13.2K 0.4% 40
2019
Q2
$825K Sell
20,081
-855
-4% -$34K 0.47% 36
2019
Q1
$844K Buy
20,936
+10,942
+109% +$438K 0.51% 32
2018
Q4
$414K Buy
9,994
+1,222
+14% +$50.7K 0.31% 40
2018
Q3
$367K Buy
8,772
+1,506
+21% +$58K 0.25% 49
2018
Q2
$250K Sell
7,266
-343
-5% -$11.7K 0.17% 63
2018
Q1
$256K Sell
7,609
-380
-5% -$13.1K 0.19% 55
2017
Q4
$275K Buy
+7,989
New +$272K 0.23% 42

Other funds holding PFE

BHK Investment Advisors's PFE Position: Q1 2023 in Review

BHK Investment Advisors sold out of Pfizer (PFE) in Q1 2023, closing a stake of 7,790 shares — an estimated $399K sold.

BHK Investment Advisors first reported a position in PFE in Q4 2017 and held it in 21 quarters. The position peaked at $844K in Q1 2019. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • BHK Investment Advisors reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • BHK Investment Advisors sold 7,790 Pfizer shares in Q1 2023, an estimated $399K.
  • BHK Investment Advisors first reported a position in Pfizer in Q4 2017 and held it in 21 quarters.
  • BHK Investment Advisors's Pfizer position peaked at $844K in Q1 2019.
  • 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on BHK Investment Advisors's 13F filing for Q1 2023, filed 9 May 2023.